Document is current
Any future updates will be listed below
-
Authors
Shigematsu, Takashi
Fukagawa, Masafumi
Yokoyama, Keitaro
Akiba, Takashi
Fujii, Akifumi
Odani, Motoi
Akizawa, Tadao
,
Kukita, K.
Sunaoshi, K.
Sato, T.
Fukaya, Y.
Kobayashi, M.
Takemura, K.
Ito, K.
Morioka, J.
Oshima, J.
Takeda, F.
Fujii, T.
Takao, K.
Murotani, N.
Suda, A.
Komatsu, Y.
Emoto, H.
Suzuki, T.
Ozawa, T.
Aruga, S.
Yamaguchi, Y.
Nishihara, M.
Shibata, K.
Kuji, T.
Mitsuhashi, T.
Kageyama, S.
Tsuboi, M.
Kasuga, H.
Onogi, T.
Sato, T.
Tsujimoto, Y.
Akagaki, Y.
Kodama, N.
Matsuoka, Y.
Arimoto, K.
Omoto, M.
Yuasa, K.
Ota, K.
Hazama, T.
Higashi, H.
Mitsuiki, K.
Otsubo, T.
-
Funding
Funding for this research was provided by:
ONO Pharmaceutical Co. Ltd. (JapicCTI-142665)
- License Information
-
More Information
Article History
Received: 22 February 2017
Accepted: 3 July 2017
First Online: 23 August 2017
Compliance with ethical standards
:
: T Shigematsu, M. Fukagawa, K. Yokoyama, T. Akiba, and T. Akizawa were the medical advisors of this study. Employment: A. Fujii, and M. Odani (Ono Pharmaceutical), Consultancies: T. Shigematsu, M. Fukagawa, T. Akiba, T. Akizawa (Ono Pharmaceutical, Kyowa Hakko Kirin), and K. Yokoyama (Ono Pharmaceutical), Honoraria: T. Shigematsu, M. Fukagawa, T. Akiba, K. Yokoyama, T. Akizawa (Ono Pharmaceutical, Kyowa Hakko Kirin), Research funding; T. Shigematsu, M. Fukagawa, T. Akiba (Kyowa Hakko Kirin).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number ONO-5163-04) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
